1,227 results match your criteria: "Don Calabria Hospital[Affiliation]"
BMC Ophthalmol
August 2024
Department of Ophthalmology, IRRCS Sacro Cuore-Don Calabria Hospital, Negrar, Italy.
Invest Ophthalmol Vis Sci
August 2024
Department of Ophthalmology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Purpose: To investigate retinal wound healing, we created a new porcine model of retinal hole and identified the cells involved in hole closure.
Methods: Sixteen landrace pigs underwent vitrectomy, and a subretinal bleb was created before cutting a retinal hole using a 23G vitrector. No tamponade was used.
Clin Transl Radiat Oncol
September 2024
Department of Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, Viale Luigi Rizzardi, 4, 37024, Negrar di Valpolicella VR, Italy.
Metabolism
November 2024
Department of Medicine, University of Verona, Italy; Metabolic Diseases Research Unit, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, Italy. Electronic address:
PLoS Negl Trop Dis
August 2024
Department of Infectious-Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Background: Infection with the filarial nematode Loa loa, endemic in Central and Western Africa, has been associated with increased morbidity and mortality. A number of reports described the presence of spleen nodules, originating from degenerating microfilariae, in humans and animals infected with L. loa.
View Article and Find Full Text PDFJ Travel Med
October 2024
Department of Infectious-Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Imported cases of Oropouche fever were recently detected in Italy. Upcoming mass events, i.e.
View Article and Find Full Text PDFLiver Int
November 2024
Section of Gastroenterology and Hepatology, Dipartimento Di Promozione Della Salute, Materno Infantile, Medicina Interna e Specialistica Di Eccellenza (PROMISE), University of Palermo, Palermo, Italy.
Importance: The recent change in terminology from nonalcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) highlights the link between hepatic steatosis and metabolic dysfunction, taking out the stigmata of alcohol.
Objective: We compared the effects of NAFLD and MAFLD definitions on the risk of overall and cardiovascular (CV) mortality, liver-related events (LRE), nonfatal CV events (CVE), chronic kidney disease (CKD), and extra-hepatic cancers (EHC).
Data Sources And Study Selection: We systematically searched four large electronic databases for cohort studies (published through August 2023) that simultaneously used NAFLD and MAFLD definitions for examining the risk of mortality and adverse CV, renal, or oncological outcomes associated with both definitions.
Cardiovasc Diabetol
August 2024
Department of Medicine, University of Verona, Verona, Italy.
Lancet
August 2024
Department of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria hospital, Verona 37024, Italy. Electronic address:
Metabolism
November 2024
MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, Zhejiang, China. Electronic address:
Background: Common metabolic diseases, such as type 2 diabetes mellitus (T2DM), hypertension, obesity, hypercholesterolemia, and metabolic dysfunction-associated steatotic liver disease (MASLD), have become a global health burden in the last three decades. The Global Burden of Disease, Injuries, and Risk Factors Study (GBD) data enables the first insights into the trends and burdens of these metabolic diseases from 1990 to 2021, highlighting regional, temporal and differences by sex.
Methods: Global estimates of disability-adjusted life years (DALYs) and deaths from GBD 2021 were analyzed for common metabolic diseases (T2DM, hypertension, obesity, hypercholesterolemia, and MASLD).
Neurology
September 2024
From the Innovation Biomedicine Section (J.P., A.C., G.C., D.F.), Department of Engineering for Innovation Medicine, University of Verona; UOC Neuropsichiatria Infantile (J.P., R.D.C., S.S., A.C., T.L.B., G.C., E.F., E.F., D.F.), Dipartimento Materno-Infantile, Azienda Ospedaliero-Universitaria Integrata, Verona, Italy; Dipartimento di Neuroradiologia (A.B., M.P.), Azienda Ospedaliera Universitaria Integrata Verona, Ospedale Civile Maggiore, Borgo Trento, Verona; Department of Neuroscience and Surgery of the Nervous System (A.L.), Papa Giovanni XXIII Hospital, Bergamo; Neuropsichiatria Infantile (F.P.), IRCCS "Sacro Cuore-Don Calabria" Hospital, Negrar, Verona; and Center for Research on Epilepsies in Pediatric Age (CREP) (G.C., E.F., E.F., B.D.B., D.F.), Verona, Italy.
J Transl Med
August 2024
Department of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Verona, Negrar, Italy.
Lancet Infect Dis
October 2024
Department of Infectious-Tropical Diseases and Microbiology, Istituto di Ricovero e Cura a Carattere Scientifico Sacro Cuore Don Calabria Hospital, Verona 37024, Italy; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
J Travel Med
August 2024
National Institute for Health, Migration and Poverty (INMP), 00153 Rome, Italy.
J Clin Med
July 2024
Department of Orthopaedics, IRCCS Ospedale Sacro Cuore Don Calabria, 37024 Negrar, Italy.
: The aim was to assess the diagnostic accuracy of DECT in diagnosing Achilles tendon tears, using MRI as the reference for diagnosis. : This feasibility study conducted prospectively at a single center included consecutive patients suffering from ankle pain who underwent DECT and MRI between April 2023 and October 2023. A total of three radiologists, blinded to the patient's clinical data, assessed the images.
View Article and Find Full Text PDFAnimals (Basel)
August 2024
Department DiMePre-J, Veterinary Section, University of Bari "Aldo Moro", Strada Provinciale Casamassima km3, Valenzano, 70010 Bari, Italy.
Antimoniate therapy, in association with allopurinol, is one of the first-line treatments of canine leishmaniasis (CanL). This study evaluates the potential adverse effects associated with aNm in the treatment of CanL through both a retrospective analysis and a long-term prospective study also aimed to investigate its efficacy. The retrospective study reviewed records of 87 dogs with CanL with at least one follow-up available during or at the end of therapy with aNm (Glucantime) at a dose of 50 mg/kg administered subcutaneously twice a day in association with allopurinol.
View Article and Find Full Text PDFCancers (Basel)
July 2024
Thoracic Oncology Functional Unit, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Rue Meylemeersch 90, 1070 Brussels, Belgium.
Patients with stage III NSCLC with N2 lymph node involvement carry a complex and diverse disease entity. Challenges persist in the areas of diagnosis, staging, multimodal management, and the determination of surgical indications and resectability criteria. Therefore, this review focuses on the latest updates in N2 disease staging and its prognostic and treatment implications.
View Article and Find Full Text PDFDermatol Pract Concept
July 2024
Medical Genetics, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.
Int J Radiat Oncol Biol Phys
January 2025
Department of Radiation Oncology, University Medical Center of Schleswig-Holstein, Kiel, Germany. Electronic address:
Purpose: STereotactic Arrhythmia Radioablation (STAR) showed promising results in patients with refractory ventricular tachycardia. However, clinical data are scarce and heterogeneous. The STOPSTORM.
View Article and Find Full Text PDFCurr Obes Rep
December 2024
Department of Metabolic and Bariatric Surgery, The First Affiliated Hospital of Jinan University, No. 613 Huangpu Avenue West, Guangzhou, China.
Discov Oncol
August 2024
Department of Radiation Oncology, Justus-Liebig-University Giessen, Giessen-Marburg University Hospital, Klinikstraße 33, 35392, Giessen, Germany.
Background: We retrospectively investigate feasibility and safety of whole brain radiotherapy (WBRT) including a simultaneous-integrated boost technique (WBRT-SIB) in a cohort of patients with a very poor prognosis suffering from multiple and/or large brain metastases, unfavorable primary histology, poor performance status and/or symptomatic BMs.
Materials And Methods: Thirty-five patients with high brain tumor burden, extracranial metastases and low life-expectancy were treated with WBRT-SIB mostly with 35-42 Gy/14 fractions. All metastases were boosted in patients with up to 12 BMs.
Radiother Oncol
October 2024
Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Aim: To evaluate acute toxicity at 6 months after stereotactic body radiotherapy (SBRT) in patients with oligometastatic cancer within the OligoCare cohort.
Material And Methods: OligoCare is a prospective, registry-based, single-arm, observational study that aims to report prospective real-world data of patients with oligometastases from solid cancer treated with SBRT (NCT03818503). Primary tumor included non-small cell lung cancer (NSCLC), breast cancer (BC), colorectal cancer (CRC), and prostate cancer (PC).
EJNMMI Radiopharm Chem
August 2024
Department of Environmental and Prevention Sciences, University of Ferrara, Via L. Borsari, 46, 44121, Ferrara, Italy.
Background: The integration of positron emission tomography (PET) and magnetic resonance imaging (MRI) holds promise for advancing diagnostic imaging capabilities. The METRICS project aims to develop cyclotron-driven production of Mn for PET/MRI imaging.
Results: Using the Cr(p,n)Mn reaction, we designed chromium metal targets via Spark Plasma Sintering and developed a separation procedure for isolating Mn.
Gut
October 2024
MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Clin Exp Metastasis
October 2024
Radiotherapy and Radiosurgery Department, IRCCS Humanitas Research Hospital, Milan, Italy.
Background: The Study Group for the Biology and Treatment of the OligoMetastatic Disease on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) has conducted a national survey with the aim to depict the current patterns of practice of stereotactic body radiotherapy (SBRT) for spinal oligometastases.
Methods: The Surveymonkey platform was used to send a 28-items questionnaire focused on demographic, clinical and technical aspects related to SBRT for spinal oligometastases. All the AIRO members were invited to fill the questionnaire.